Currency: AUD
Period
H1 FY2024 Earnings
--
3.60M
-0.07
Strong Buy
Feb 1, 2024
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Genetic Signatures Ltd: 1H 24 Market Update
Feb 21 17:31 ET
Genetic Signatures Ltd: Half Yearly Report and Accounts
Genetic Signatures Ltd: Investor Webinar - FY2023 Results and US FDA 510(k)
Sep 3, 2023 18:53 ET
Genetic Signatures Ltd: Appendix 4E and Annual Report
Aug 30, 2023 20:44 ET
Read more
Updated: Feb 1, 2024
Buy
Hold
Underperform
Sell
No Data